GE HealthCare Technologies Inc.
GEHC
$86.01
-$0.575-0.66%
| Weiss Ratings | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.82 | |||
| Price History | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.78% | |||
| 30-Day Total Return | -2.99% | |||
| 60-Day Total Return | 5.07% | |||
| 90-Day Total Return | -2.68% | |||
| Year to Date Total Return | 9.79% | |||
| 1-Year Total Return | -8.23% | |||
| 2-Year Total Return | 12.60% | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -8.67% | |||
| 52-Week Low % Change | 16.20% | |||
| Price | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $94.80 | |||
| 52-Week Low Price | $74.51 | |||
| 52-Week Low Price (Date) | Jun 11, 2024 | |||
| 52-Week High Price (Date) | Feb 13, 2025 | |||
| Valuation | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 39.59B | |||
| Enterprise Value | 46.30B | |||
| Price/Earnings (TTM) | 20.00 | |||
| Earnings Per Share (TTM) | 4.33 | |||
| Earnings Per Share Growth | 43.32% | |||
| Price/Earnings To Growth | 0.46 | |||
| Price/Sales (TTM) | 2.02 | |||
| Price/Book (Q) | 4.68 | |||
| Enterprise Value/Revenue (TTM) | 2.35 | |||
| Price | $86.02 | |||
| Enterprise Value/EBITDA (TTM) | 12.85 | |||
| Enterprise Value/EBIT | 15.31 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 459.00M | |||
| Dividend Yield | 0.14% | |||
| Div. Per Share (Most Recent) | $0.04 | |||
| Dividend Per Share (TTM) | $0.13 | |||
| Payout Ratio (TTM) | 2.11% | |||
| Dividend Per Share (Most Recent) | $0.04 | |||
| Company Info | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 833 735 1139 | |||
| Address | 500 West Monroe Street Chicago, IL 60661 | |||
| Website | www.gehealthcare.com | |||
| Country | United States | |||
| Year Founded | 2022 | |||
| Profitability | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 15.37% | |||
| Profit Margin | 10.13% | |||
| Management Effectiveness | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 5.77% | |||
| Return on Equity | 25.69% | |||
| Income Statement | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 19.67B | |||
| Total Revenue (TTM) | 19.67B | |||
| Revenue Per Share | $42.86 | |||
| Gross Profit (TTM) | 8.20B | |||
| EBITDA (TTM) | 3.60B | |||
| EBIT (TTM) | 3.02B | |||
| Net Income (TTM) | 1.99B | |||
| Net Income Avl. to Common (TTM) | 1.99B | |||
| Total Revenue Growth (Q YOY) | 2.17% | |||
| Earnings Growth (Q YOY) | 77.40% | |||
| EPS Diluted (TTM) | 4.33 | |||
| EPS Diluted Growth (Q YOY) | 78.41% | |||
| Balance Sheet | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 2.87B | |||
| Cash Per Share (Q) | $6.26 | |||
| Total Current Assets (Q) | 9.90B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 8.65B | |||
| Current Ratio (Q) | 1.036 | |||
| Book Value Per Share (Q) | $18.48 | |||
| Total Assets (Q) | 33.09B | |||
| Total Current Liabilities (Q) | 9.55B | |||
| Total Debt (Q) | 9.38B | |||
| Total Liabilities (Q) | 24.44B | |||
| Total Common Equity (Q) | 8.45B | |||
| Cash Flow | GEHC - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -777.00M | |||
| Cash from Financing (TTM) | -1.49B | |||
| Net Change in Cash (TTM) | -1.17B | |||
| Levered Free Cash Flow (TTM) | 1.28B | |||
| Cash from Operations (TTM) | 1.21B | |||
